Company Name: |
Ningbo Benkang jishi Pharmaceutical Technology Co., Ltd.
|
Tel: |
15990591583 |
Email: |
|
Products Intro: |
Product Name:1 -{3-[7-(difluoromethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-1 (2H)-yl]-1 -(oxan-4-yl)-1,4,6.7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}ethan-1-one CAS:1936429-31-0 Purity:96% HPLC Package:1g;10g;100g;1kg;5kg
|
|
| 1 -{3-[7-(difluoromethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-1 (2H)-yl]-1 -(oxan-4-yl)-1,4,6.7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}ethan-1-one Basic information |
Product Name: | 1 -{3-[7-(difluoromethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-1 (2H)-yl]-1 -(oxan-4-yl)-1,4,6.7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}ethan-1-one | Synonyms: | 1 -{3-[7-(difluoromethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-1 (2H)-yl]-1 -(oxan-4-yl)-1,4,6.7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}ethan-1-one;Ethanone, 1-[3-[7-(difluoromethyl)-3,4-dihydro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1(2H)-quinolinyl]-1,4,6,7-tetrahydro-1-(tetrahydro-2H-pyran-4-yl)-5H-pyrazolo[4,3-c]pyridin-5-yl]- | CAS: | 1936429-31-0 | MF: | C29H39BF2N4O4 | MW: | 556.46 | EINECS: | | Product Categories: | | Mol File: | 1936429-31-0.mol | |
| 1 -{3-[7-(difluoromethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-1 (2H)-yl]-1 -(oxan-4-yl)-1,4,6.7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}ethan-1-one Chemical Properties |
Boiling point | 757.8±60.0 °C(Predicted) | density | 1.32±0.1 g/cm3(Predicted) | pka | 2.07±0.20(Predicted) |
| 1 -{3-[7-(difluoromethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-1 (2H)-yl]-1 -(oxan-4-yl)-1,4,6.7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}ethan-1-one Usage And Synthesis |
| 1 -{3-[7-(difluoromethyl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,4-dihydroquinolin-1 (2H)-yl]-1 -(oxan-4-yl)-1,4,6.7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl}ethan-1-one Preparation Products And Raw materials |
|